Somnigroup International Inc. SGI 深 滬
等待開盤 09-22 09:30:00 美东时间
85.55
-0.460
-0.53%
華盛通- 最 高86.38
- 今 開85.81
- 成交量 355.14万股
- 最 低 85.52
- 昨 收 86.01
- 總市值 178.80亿
- 52周最高 88.15
- 市盈率 靜 --
- 換手率 1.70%
- 52周最低 47.46
- 委 比 -8.70%
- 總股本 2.09亿
- 歷史最高 103.41
- 量 比 1.94
- 振 幅 1.00%
- 歷史最低 20.03
- 每 手 1
- 風險率 9.75%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅432.99%！维持"投机性买入"评级，Unicycive Therapeutics获机构升目标价至21美元
今日重点评级关注：Benchmark：维持Unicycive Therapeutics"投机性买入"评级，目标价从3美元升至21美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从17美元升至25美元
09-16 09:48
Here's How Much $100 Invested In Somnigroup International 20 Years Ago Would Be Worth Today
Somnigroup International (NYSE:SGI) has outperformed the market over the past 2...
09-13 06:00
Stealth Group Holdings Announces Record-Breaking FY2025 Results
Stealth Global Holdings Ltd. ( ($AU:SGI) ) has issued an announcement. Stealth ...
09-03 13:47
Somnigroup International Joins 2025 Goldman Sachs Conference
Somnigroup International ( ($SGI) ) has issued an announcement. On September 2,...
09-02 19:17
拓展模具产业链纵深加码新能源汽车业务 宁波方正上半年营收增50.39%
8月28日晚间，宁波方正汽车模具股份有限公司（300998.SZ）发布2025年半年度报告显示，上半年公司实现营业收入5.82亿元，较去年同期增长50.39%...
09-01 08:30
Skechers, Tesla, and DoorDash among hedge funds’ new favorite long positions – GS
Goldman Sachs strategists highlighted their “VIP” list of stocks that “matter the most” to hedge funds, as they appear the most among their top 10 holdings. This list has outperformed the S&P 500 (SP5...
08-21 01:25
Somnigroup International Appoints New CEO for Subsidiary
Somnigroup International ( ($SGI) ) just unveiled an announcement. On August 14...
08-19 04:36
Somnigroup Names Steve Rusing CEO of Mattress Firm, Succeeding Scott Thompson's Interim Role
Somnigroup International Inc. (NYSE:SGI) announced today that Steve Rusing, currently serving as President of Mattress Firm, has expanded his leadership role to President and Chief Executive Officer, effective August 14,
08-18 18:56
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
